Vonoprazan is Efficacious for Non-Erosive Reflux Disease (NERD): An Alternative for PPI-Resistant NERD Patients? Christopher Vélez, MD Associate Program Director,…

Swathi Eluri, MD, MSCR takes an evidence-based look at a 2022 article which showed budesonide oral suspension improved outcomes in patients with EoE.

Non-Erosive GERD Does Not Lead to an Increased Risk of Esophageal Adenocarcinoma: A Nordic Population Based Cohort Study Swathi Eluri,…

The goal of surveillance is to identify low-grade or high-grade dysplasia or early cancer at a treatable stage, however, current early cancer detection practices are ineffective. One potential explanation for these limitations is PEEC/PEEN, similar to the concept of post-colonoscopy colorectal cancer and related to endoscopy quality.

Cooking Up Something New With a One-Food Elimination Diet: A Simpler Approach to  Dietary Therapy for Eosinophilic Esophagitis Jennifer M.…

Dupilumab, an IgG4 Monoclonal Antibody, for Eosinophilic Esophagitis: Revising the Treatment Paradigm Afrin Kamal, MD, MS1 and Philip Schoenfeld, MD,…

Evidence-based summary reviews Yadlapati R, Gyawali CP, Masihi M, et al. Optimal Wireless Reflux Monitoring Metrics to Predict Discontinuation of Proton Pump Inhibitor Therapy. Am J Gastroenterol. 2022 Oct 1;117(10):1573-1582. doi.org/10.14309/ajg.0000000000001871.

Vonoprazan, a Potassium-Competitive Acid Blocker, Is Superior to Lansoprazole for Managing Erosive Esophagitis Philip Schoenfeld, MD, MSEd, MSc (Epi) Chief…

Reinvestigating the Lack of Association Between Proton Pump Inhibitor Use and Mortality by Accounting for Reverse Causation Ravy K. Vajravelu,…

In Case You Missed It: Surgery is Superior to Medical Therapy for PPI-refractory Heartburn in the “Right” Patients   Jennifer…